Further reading

Dyer MJS, Hale G, Hayhoe FGJ and Waldmann H (1989) Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 73: 1431-1439. Friend PJ, Rebello P, Oliveira D et al (1995) Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody. Transplantation Proceedings 27: 869-870. Hale G and Phillips JM (1995) Clinical trials with CAM-PATH-1 and other monoclonal antibodies. Biochemical Society Transactions 23: 1057-1063. Hale G and Waldmann H (1994) CAMPATH-1 monoclonal antibodies in bone marrow transplantation. Hematotherapy 3: 15-31.

Hale G, Dyer MJS, Clark MR et al (1988) Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1 H. Lancet ii: 1394-1399.

Hale G, Rye PD, Warford A, Lauder 1 and Brito-Babapulle A (1993) The GPI-anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa. Journal of Reproductive Immunology 23: 189-205.

Isaacs JD, Watts RA, Hazleman BL et al (1992) Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet 340: 748-752.

Kirchhoff C and Hale G (1996) Cell to cell transfer of gly-cosylphosphatidylinositol-anchored membrane proteins during sperm maturation. Molecular Human Reproduction 2: 177-184.

Kirchhoff C, Krull N, Pera 1 and Ivell R (1992) A major mRNA of the human epididymal principal cells, HE5, encodes the leucocyte differentiation CDw52 antigen peptide backbone. Molecular Reproduction and Development 34: 11-15.

Lockwood CM, Thiru S, Isaacs JD, Hale G and Waldmann H (1993) Humanised monoclonal antibody treatment for intractable systemic vasculitis. Lancet 341: 1620-1622.

Mehta J, Powles R, Treleaven J et al (1997) Autologous transplantation with CD52 monoclonal antibody-purged marrow for acure lymphoblastic leukemia: long-term follow-up. Leukemia Lymphoma 25: 479-486.

Moreau T, Thorpe J, Miller D et al (1994) Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depiction in multiple sclerosis. Lancet 344: 298-301.

Osterborg A, Dyer MJ, Bunjes D et al (1997) Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1 H Treatment in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology 15: 1567-1574.

Osterborg A, Fassas AS, Anagnostopoulos A, Dyer MJ, Catovsky D and Mellstedt H (1996) Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukemia. British Journal of Hematology 93: 151-153.

Reuter H, Wraight EP, Qasim FJ and Lockwood CM (1995) Management of vasculitis: the contribution of scintigraphic imaging to the evaluation of disease activity and classification. Quarterly Journal of Medicine 88: 509-516.

Riechmann L, Clark M, Waldmann H and Winter G (1988) Reshaping human antibodies for therapy. Nature 332: 323-327.

Treumann A, Lifely R, Schneider P and Ferguson MA) (1995) Primary structure of CD52. journal of Biological Chemistry 270: 6088-6099.

Xia M-Q, Hale G, Lifely MR et al (1993) Structure of the CAMPATH-1 antigen, a GPI-anchored glycoprotein which is an exceptionally good target for complement lysis. Biochemical Journal 29: 633-640.

Was this article helpful?

0 0
Natural Arthritis Pain Remedies

Natural Arthritis Pain Remedies

It's time for a change. Finally A Way to Get Pain Relief for Your Arthritis Without Possibly Risking Your Health in the Process. You may not be aware of this, but taking prescription drugs to get relief for your Arthritis Pain is not the only solution. There are alternative pain relief treatments available.

Get My Free Ebook


Post a comment